Pitavastatin: efficacy and safety in intensive lipid lowering.
about
Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goalsPitavastatin: a new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor for the treatment of hyperlipidemia.Pleiotropic effects of pitavastatinImpact of statin treatment on strut coverage after drug-eluting stent implantation.Comparison of efficacy of intensive versus mild pitavastatin therapy on lipid and inflammation biomarkers in hypertensive patients with dyslipidemia.Statin treatment alters serum n-3 to n-6 polyunsaturated fatty acids ratio in patients with dyslipidemia.Pitavastatin: finding its place in therapy.Short-term effect of pitavastatin treatment on glucose and lipid metabolism and oxidative stress in fasting and postprandial state using a test meal in Japanese men.New evidence on pitavastatin: efficacy and safety in clinical studies.Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia.Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.Efficacy and safety of pitavastatin in Japanese patients with hypercholesterolemia: LIVES study and subanalysis.Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors.Drug-drug interactions that interfere with statin metabolism.Comparison of the pharmacokinetics of pitavastatin by formulation and ethnic group: an open-label, single-dose, two-way crossover pharmacokinetic study in healthy Caucasian and Japanese men.Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia.Pitavastatin shows greater lipid-lowering efficacy over 12 weeks than pravastatin in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia.Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia.High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.Effect of intensive statin therapy on regression of carotid intima-media thickness in patients with subclinical carotid atherosclerosis (a prospective, randomized trial: PEACE (Pitavastatin Evaluation of Atherosclerosis Regression by Intensive Choles
P2860
Q34614726-3332519D-8157-457E-8A8B-229240B617A2Q34625887-ACED8D7D-C6B2-4AE3-8764-1BE96239A9B3Q34633506-73CCA4E9-481E-4AB1-AA6D-BBFCDCF8B34FQ34774239-8BBCE0C2-8514-4E94-ADC0-ED687F88B2CFQ35106600-9F105AAC-589B-460A-892E-48402A528AE5Q35819926-2466BAAB-B583-4986-BD89-9B937F82DFC7Q36443716-4219887B-4A80-451B-A91C-163BBE6F04A8Q37413198-35C484D0-8CDB-44A1-9E1F-86DF1A60DC52Q37702244-1DD5CE39-DCE3-4B1D-8014-9422D5B0A338Q37776512-CD259744-E02B-4370-B33C-56FAC699CDE3Q37859000-00486B81-1387-467D-B34D-7F354B4DD2D5Q37880123-948DEB9B-2933-46EE-A5F8-AEEE7B5D3F1AQ38109095-0EFBCF5C-DBF5-4B80-9BC2-5D6ACD37EB06Q38522299-8A33A9CA-8505-4944-962D-7EDF4A5A4CB2Q42614556-5F2ACFD8-8918-4D14-AD44-9C025119E059Q43152513-74FBED00-A241-42A0-B996-520C441A9E8BQ46410210-B0D5CBD7-3F2F-4579-B2EF-AE72F3CFA324Q51369965-741E69AE-3E83-4FE7-8F4C-0B85A9CF8891Q55183786-CD25FDB2-2EE3-4A78-977F-1CEA3AA49E0AQ57097359-4C0675F0-1873-40FD-BBA8-D80495CF1BE7
P2860
Pitavastatin: efficacy and safety in intensive lipid lowering.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pitavastatin: efficacy and safety in intensive lipid lowering.
@en
type
label
Pitavastatin: efficacy and safety in intensive lipid lowering.
@en
prefLabel
Pitavastatin: efficacy and safety in intensive lipid lowering.
@en
P2093
P2860
P1476
Pitavastatin: efficacy and safety in intensive lipid lowering.
@en
P2093
Akihisa Iguchi
Koutaro Yokote
Toshio Hayashi
Yasushi Saito
P2860
P304
P356
10.1517/14656566.8.14.2315
P407
P577
2007-10-01T00:00:00Z